Identification of TRIB1 R107L gain-of-function mutation in human acute megakaryocytic leukemia

Blood

Volumn 119, Issue 11, 2012, Pages 2608-2611

  Yokoyama, Takashi ^a   Toki, Tsutomu ^b   Aoki, Yoshihiro ^b   Kanezaki, Rika ^b   Park, Myoung Ja ^c   Kanno, Yohei ^a   Takahara, Tomoko ^a   Yamazaki, Yukari ^a   Ito, Etsuro ^b   Hayashi, Yasuhide ^c   Nakamura, Takuro ^a  

^a CANCER INSTITUTE   (Japan)

^b HIROSAKI UNIVERSITY   (Japan)

^c Gumna Children S Medical Center   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; LEUCINE;

ACUTE MEGAKARYOCYTIC LEUKEMIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN SYNDROME; FEMALE; GAIN OF FUNCTION MUTATION; GENE IDENTIFICATION; HUMAN; HUMAN CELL; LEUKEMOGENESIS; MALE; MOUSE; NONHUMAN; ONCOGENE; PRIORITY JOURNAL; PROTEIN FUNCTION; TRIB 1 GENE;

EID: 84863391280     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2010-12-324806     Document Type: Article

References (12)

1. Shimizu R, Engel JD, Yamamoto M. GATA1-related leukaemias. Nat Rev Cancer. 2008;8(4):279-287. (Pubitemid 351430864)
2. Jin G, Yamazaki Y, Takuwa M, et al. Trib1 and Evi1 cooperate with Hoxa and Meis1 in myeloid leukemogenesis. Blood. 2007;109(9):3998-4005. (Pubitemid 46641753)
3. Kiss-Toth E, Bagstaff SM, Sung HY, et al. Human Tribbles, a protein family controlling mitogen-activated protein kinase cascades. J Biol Chem. 2004;279(41):42703-42708. (Pubitemid 39372156)
4. Yokoyama T, Kanno Y, Yamazaki Y, et al. Trib1 links the MEK/ERK pathway in myeloid leukemogenesis. Blood. 2010;116(15):2768-2775.
5. Keeshan K, He Y, Wouters BJ, et al. Tribbles homolog 2 inactivates C/EBPalpha and causes acute myelogenous leukemia. Cancer Cell. 2006;10(5):401-411. (Pubitemid 44767839)
6. Storlazzi CT, Fioretos T, Surace C, et al. MYC-containing double minutes in hematologic malignancies: evidence in favor of the episome model and exclusion of MYC as the target gene. Hum Mol Genet. 2006;15(6):933-942. (Pubitemid 43338234)
7. Kanezaki R, Toki T, Terui K, et al. Down syndrome and GATA1 mutations in transient abnormal myeloproliferative disorder: mutation classes correlate with progression to mye loid leukemia. Blood. 2010;116(22):4631-4638.
8. Kogan SC, Ward JM, Anver MR, et al. Bethesda proposal for classification of nonlymphoid hematopoietic neoplasms in mice. Blood. 2002;100(1):238-245. (Pubitemid 35177453)
9. Toki T, Kanezaki R, Adachi S, et al. The key role of stem cell factor/KIT signaling in the proliferation of blast cells from Down syndrome-related leukemia. Leukemia. 2009;23(1):95-103.
10. Hegedus Z, Czibula A, Kiss-Toth E. Tribbles: a family of kinase-like proteins with potent signaling regulatory function. Cell Signal. 2007;19(2):238-250. (Pubitemid 44969976)
11. Yokoyama T, Nakamura T. Tribbles in disease: signaling pathways important for cellular function and neoplastic transformation. Cancer Sci. 2011;102(6):1115-1122.
12. Dedhia PH, Keeshan K, Uljon S, et al. Differential ability of Tribbles family members to promote degradation of C/EBPalpha and induce acute myelogenous leukemia. Blood. 2010;116(8):1321-1328.